Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Minister Jabak Toured El Hermel's Hospitals and Promised to Secure the Necessary Equipment

 
After the welcoming address of MP Hamadeh, Minister Jabak thanked the warm reception, stressing on the work to put Hermel of the Health map, support the hospitals and health care centers, provide the needed equipment and health services, raise the financial ceiling of the region’s hospitals and provide the necessary medicines without the need to wait at the doors.
 
Jabak then moved to Hermel Governmental Hospital where he was received by the chairman of the board of directors Simon Naser Eddine and the Medical Director Hossein Sakr, before he toured the departments of the hospital to identify its need.
 
Jabak expressed shock at the lack of a cardiac care unit and an equipped ambulance response unit for an area with a population of over 100 000. “We aim at securing the necessary equipment, developing a blood bank and raising the financial ceiling. The funds have already been allocated for the rehabilitation of the governmental hospitals, pending submission of details of an integrated project with the MPs,” Jabak added.
 
Jabak visited later Batoul Hospital and Al Assi Hospital.
    2
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet L.L
L01AA01 ENDOXAN B Cyclophosphamide (monohydrate) - 500mg 500mg Injectable powder for solution L.L
L01AA09 BENDAVIVAL G Bendamustine HCl - 100mg 100mg Injectable concentrated powder for solution L.L
L04AA06 MYFORTIC B Mycophenolic acid (sodium) - 360mg 360mg Tablet, gastroresistant L.L
L04AC10 COSENTYX BioTech Secukinumab - 150mg/ml 150mg/ml Injectable solution L.L
S01LA04 LUCENTIS BioTech Ranibizumab - 10mg/ml 10mg/ml Injectable solution L.L
S01LA06 BEOVU BioTech Brolucizumab - 120mg/ml 120mg/ml Injectable solution L.L
L01EA04 BOSULIF B Bosutinib - 100mg 100mg Tablet, film coated L.L
L01ED05 LORBRENA B Lorlatinib - 100mg 100mg Tablet L.L
L01FX02 MYLOTARG BioTech Gemtuzumab Ozogamicin - 4.5mg 4.5mg Injectable powder L.L
L01FB01 BESPONSA FOR INJECTION BioTech Inotuzumab Ozogamicin - 0.9mg 0.9mg Injectable powder for suspension L.L
L01BA04 PEMETREXED NEAPOLIS G Pemetrexed (disodium) - 100mg 100mg Injectable solution L.L
L01BB05 FLUDARABINE PHOSPHATE NEAPOLIS G Fludarabine Dihydrogenophosphate - 50mg/2ml 50mg/2ml Injectable solution L.L
B03XA01 EPOMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 4000UI/ml 4000UI/ml Injectable solution L.L
L04AB04 ADALIREL BioTech Adalimumab - 40mg 40mg Injectable solution L.L
B05AA01 ALBUREL HUMAN ALBUMIN BP BioHuman Albumin human - 20% 20% Injectable solution L.L
L02BB04 ENZASTIK 40 G Enzalutamide - 40mg 40mg Capsule L.L
L01EA03 TASIGNA B Nilotinib - 200mg 200mg Capsule L.L
L03AX03 BCG-MEDAC G BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units Injectable powder for suspension+diluent L.L
L04AA52 KESIMPTA BioTech Ofatumumab - 20mg/0.4ml 20mg/0.4ml Injectable solution L.L
L01XX52 VENCLEXTA B Venetoclax - 100mg 100mg Tablet L.L
S01LA05 EYLEA BioTech Aflibercept - 40mg/ml 40mg/ml Injectable solution L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 40,000IU 40,000IU Injectable freeze dried powder + diluent L.L
B03XA01 HEMAX BioTech Erythropoietin recombinant human (Epoetin alfa) - 10,000IU 10,000IU Injectable freeze dried substance+diluent L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable solution L.L
L01EA03 TASIGNA B Nilotinib - 150mg 150mg Capsule L.L
L04AC16 TREMFYA BioTech Guselkumab - 100mg/ml 100mg/ml Injectable solution L.L
L04AC05 STELARA BioTech Ustekinumab - 130mg 130mg Injectable concentrate for solution L.L
V03AC03 DEFIROX G Deferasirox - 500mg 500mg Tablet, dispersible L.L
L01BB04 MAVENCLAD B Cladribine - 10mg 10mg Tablet L.L
    2
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025